Cambridge Healthtech Institute’s 2nd Annual

Artificial Intelligence in Precision Medicine

AI Revolution in Personalized Therapy, Precision Oncology, and Medicine

March 11-12, 2025

Advances in artificial intelligence and generative AI are transforming discovery, drug development, diagnostics, and delivery of healthcare. Cambridge Healthtech Institute’s 2nd Annual Artificial Intelligence in Precision Medicine meeting will explore the potential of AI-driven technologies to redefine personalized medicine. AI thought leaders will discuss AI-driven discovery from genomic and medical data, precision medicine drug discovery and development, impact of generative AI on healthcare delivery, utility of AI in precision oncology, digital medicine and mobile health integration, and impact of AI on healthcare equity and accessibility. The meeting will assemble key stakeholders from technology companies, academia, pharma, healthcare providers, payers, and government to brainstorm the opportunities, challenges, and strategies in the inevitable AI revolution.

Coverage will include, but is not limited to:

Convergence of AI and genomics
AI tools in drug discovery and personalized medicine
Clinical applications of generative AI
AI for precision oncology
AI in diagnostics and laboratory stewardship
AI in radiology and pathology
AI-enabled accessibility and equity
AI as productivity tool in clinical decision making
AI-enabled digital medicine and mobile health

The deadline for priority consideration is August 16, 2024.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: